Literature DB >> 2430187

Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease.

J C Burns, R S Geha, E E Schneeberger, J W Newburger, F S Rosen, L S Glezen, A S Huang, J Natale, D Y Leung.   

Abstract

Kawasaki disease (KD) is an acute vasculitis of infancy and early childhood characterized by high fever, rash, mucositis, lymphadenopathy and coronary artery damage. Large epidemics have been described in Japan and the United States and the number of cases reported annually is steadily increasing. The aetiology of KD is unknown. During the acute phase of the disease marked immunologic alterations occur including generalized T-cell lymphocytopenia, activation of circulating T4+ helper T cells, decreased numbers of T8+ suppressor T cells and marked B-cell activation. We postulated that a lymphotropic virus with affinity for endothelial and lymphoid cells might explain the vasculitis and immunological abnormalities in KD. We report here our study of the particulate fraction from culture supernatants of peripheral blood mononuclear cells (PBMC) for evidence of retrovirus-associated reverse transcriptase (RT) activity. Activity was found in the supernatants from KD patients but not control cultures. This RT activity was transmitted to an established T-cell line (HUT-78) and thus may be due to an exogenous agent infecting KD lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430187     DOI: 10.1038/323814a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  20 in total

1.  Selective depletion and activation of CD8+ lymphocytes from peripheral blood of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  B Dasgupta; O Duke; A M Timms; C Pitzalis; G S Panayi
Journal:  Ann Rheum Dis       Date:  1989-04       Impact factor: 19.103

2.  Antibodies to native type III collagen in the serum of patients with Kawasaki disease.

Authors:  S Kobayashi; N Wada; M Kubo
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

Review 3.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

Review 4.  Genetic engineering of antiviral agents.

Authors:  A S Huang; J Böni
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

Review 5.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

6.  Clinical aspects of 100 patients with Kawasaki disease.

Authors:  E J Tizard; A Suzuki; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

7.  Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease.

Authors:  E J Tizard; E Baguley; G R Hughes; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

Review 8.  Retroviruses and human disease.

Authors:  R A Weiss
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

9.  Evidence for a superantigen mediated process in Kawasaki disease.

Authors:  N Curtis; R Zheng; J R Lamb; M Levin
Journal:  Arch Dis Child       Date:  1995-04       Impact factor: 3.791

10.  A sensitive method for the identification of uncharacterized viruses related to known virus groups: hepadnavirus model system.

Authors:  D H Mack; J J Sninsky
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.